Abiraterone Acetate 500 mg

Abiraterone Acetate 500 mg

Product Overview

Generic NameAbiraterone Acetate 500 mg
Brand Name(s)ZYTIGA®
CategoryAntineoplastic / Cancer
Form60 Oral Tablets, plastic bottle
Strength500 mg
Therapeutic ClassCancer, Hormone antagonists and related agents
ATC CodeL02BX03

Manufacturing & Regulatory

ManufacturerJanssen Biotech
GMP ComplianceW.H.O.
DMF/CEPType II: API DMFs
COFEPRIS010.000.6211.00
Free Sale CertificateYes

Logistics & Export

MOQ10 bottles
Shelf Life24 Months
StorageControlled room temperature 20–25 °C
IncotermsEx-Works, 30049099
Lead Time7 - 10 Business Days

Documentation Available Upon Request

Certificate of Analysis (PDF)Yes
GMP Certificate (PDF)Yes
SDS-Safety Data Sheet (PDF)Upon Request
CTD Summary (PDF)Upon Request

Special Notes

Indications & Usage: Treats prostate cancer advanced metastatic.
Description: INN: Abiraterone Acetate

  • Strength: 500 mg
  • Dosage Form: Tablet
  • Presentation: Box of 60 tablets
  • CNIS/Clave: 010.000.6211.00
  • Product Type: Generic procurement presentation
  • Therapeutic Class: Androgen Biosynthesis Inhibitor (CYP17 inhibitor)
  • ATC Code: L02BX03